naa a22 4500 510763596 CHVBK 20180411083148.0 cr unu---uuuuu 180411e20131201xx s 000 0 eng 10.1007/s12094-013-1085-2 doi (NATIONALLICENCE)springer-10.1007/s12094-013-1085-2 SEOM clinical guidelines for the treatment of non-small cell lung cancer (NSCLC) 2013 [Elektronische Daten] [C. Camps, E. Felip, R. García-Campelo, J. Trigo, P. Garrido] Lung cancer remains the most commonly diagnosed cancer worldwide and the leading cause of cancer-related mortality. More than 80% of all newly diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). Despite recent advances, 40% of patients still have advanced disease at the moment of diagnosis. Clinical information, pathological diagnosis and molecular assessment are needed to guide the systemic therapy, whereas discussion within an experienced team is key to adequately select the most appropriate multidisciplinary strategies. The purpose of this article is to provide updated recommendations for the management of these patients. Federación de Sociedades Españolas de Oncología (FESEO), 2013 Non-small cell lung cancer nationallicence Chemotherapy nationallicence Surgery nationallicence Radiotherapy nationallicence Epidermal growth factor receptor (EGFR) nationallicence Tyrosine kinase inhibitors (TKIs) nationallicence Camps C. Medical Oncology Department, Hospital General Universitario, Valencia, Spain aut Felip E. Medical Oncology Department, Hospital Vall d'Hebrón, Barcelona, Spain aut García-Campelo R. Medical Oncology Department, Complexo Hospitalario Universitario A Coruña, A Coruña, Spain aut Trigo J. Medical Oncology Department, Hospital Universitario Virgen de la Victoria, Málaga, Spain aut Garrido P. Medical Oncology Department, IRYCIS. Hospital Universitario Ramón Y Cajal, Carretera Colmenar Viejo Km 9, 100, 28034, Madrid, Spain aut Clinical and Translational Oncology Springer Milan 15/12(2013-12-01), 977-984 1699-048X 15:12<977 2013 15 12094 https://doi.org/10.1007/s12094-013-1085-2 text/html Onlinezugriff via DOI 1 review-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/s12094-013-1085-2 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Camps C. Medical Oncology Department, Hospital General Universitario, Valencia, Spain aut NATIONALLICENCE 700 1- Felip E. Medical Oncology Department, Hospital Vall d'Hebrón, Barcelona, Spain aut NATIONALLICENCE 700 1- García-Campelo R. Medical Oncology Department, Complexo Hospitalario Universitario A Coruña, A Coruña, Spain aut NATIONALLICENCE 700 1- Trigo J. Medical Oncology Department, Hospital Universitario Virgen de la Victoria, Málaga, Spain aut NATIONALLICENCE 700 1- Garrido P. Medical Oncology Department, IRYCIS. Hospital Universitario Ramón Y Cajal, Carretera Colmenar Viejo Km 9, 100, 28034, Madrid, Spain aut NATIONALLICENCE 773 0- Clinical and Translational Oncology Springer Milan 15/12(2013-12-01), 977-984 1699-048X 15:12<977 2013 15 12094 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer